why choose us

First received: May 18, 2023

Clinical Trial: A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Essential Hypertension

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy in Comparison With Fimasartan Monotherapy for Essential Hypertension Patients

Brief Summary: The objective of this clinical trial is to evaluate the efficacy and safety of BR1015 Combination therapy group in comparison with Fimasartan monotherapy group at Week 8 for essential hypertension patients who do not adequately responded by Fimasartan 30 mg

Read more